Celestial Biolabs Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported sales of INR 76.690 million compared to INR 65.849 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 9.569 million compared to INR 7.508 million a year ago. Profit from ordinary activities before tax was INR 4.412 million compared to INR 5.793 million a year ago. Profit from ordinary activities after tax was INR 3.596 million compared to INR 4.721 million a year ago. Net profit for the period was INR 3.596 million compared to INR 4.721 million a year ago. Basic and diluted earnings per share were INR 0.21 compared to INR 0.32 a year ago.

For the nine months, the company reported sales of INR 222.761 million compared to INR 152.993 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 25.718 million compared to INR 17.012 million a year ago. Profit from ordinary activities before tax was INR 12.047 million compared to INR 11.867 million a year ago. Profit from ordinary activities after tax was INR 9.819 million compared to INR 9.672 million a year ago. Net profit for the period was INR 9.819 million compared to INR 9.672 million a year ago. Basic and diluted earnings per share were INR 0.57 compared to INR 0.66 a year ago.